OncoCyte (OCX)
(Delayed Data from NSDQ)
$2.48 USD
+0.04 (1.64%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.44 -0.04 (-1.61%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Earnings News For OCX
-
OncoCyte: Q3 Earnings Snapshot
-
Oncocyte Reports Third Quarter 2023 Financial Results
-
OncoCyte: Q2 Earnings Snapshot
-
OncoCyte: Q1 Earnings Snapshot
-
Oncocyte Reports First Quarter 2023 Financial Results
-
Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K
-
Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call
-
OncoCyte (OCX) Reports Q3 Loss, Misses Revenue Estimates
-
OncoCyte: Q3 Earnings Snapshot
-
Oncocyte Reports Third Quarter 2022 Financial Results
-
OncoCyte: Q2 Earnings Snapshot
-
OncoCyte (OCX) Reports Q2 Loss, Misses Revenue Estimates
-
OncoCyte (OCX) Reports Q1 Loss, Lags Revenue Estimates
-
OncoCyte (OCX) Q4 Earnings Match Estimates, Revenues Lag (Revised)
-
OncoCyte (OCX) Reports Q4 Loss, Lags Revenue Estimates
-
OncoCyte (OCX) Reports Q3 Loss, Lags Revenue Estimates
-
Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should Know
-
OncoCyte (OCX) Reports Q2 Loss, Tops Revenue Estimates
-
Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should Know
-
Will OncoCyte (OCX) Report Negative Q1 Earnings? What You Should Know
-
OncoCyte (OCX) Reports Q4 Loss, Misses Revenue Estimates
-
OncoCyte (OCX) Reports Q2 Loss, Tops Revenue Estimates